PRIMARY TRACK: Guideline implementation SECONDARY TRACK: Performance measures/indicators/ quality incentives and guidelines BACKGROUND (INTRODUCTION): One popular method to implement guidelines and improve care is the Breakthrough Collaborative Method. Central characteristics of this method are: the use of guidelines, multi-institutional work groups, a national expert team, meetings and learning sessions, data collection, and continuous feedback loops. In this presentation we will illustrate the Breakthrough method and its implementation power, using the Depression Breakthrough Collaborative as an example. This project was initiated from 2006 to 2008 in the Netherlands to take away the gap between daily practice and guideline recommendations. Proper recognition of depression, a reduction of overtreatment of minor and mild depressions with antidepressants, and a reduction of undertreatment of patients with more severe symptoms were the goals to be reached. To do so, teams of professionals implemented a Stepped Care Depression Model, based on the guidelines. Parallel to the Collaborative, a study was performed into the uptake of the guideline recommendations, clinical outcomes, and costs.
LEARNING OBJECTIVES (TRAINING GOALS):
1. Understand the processes, gains, and limitations of the Collaborative method for guideline implementation purposes. 2. Have knowledge of key factors to be considered before opting for this or a similar complex implementation method. 3. Reflect on adaptations of the Collaborative method, so that it can fit to other topics and circumstances. 2. Understand advantages and disadvantages of different methods for developing quality indicators within guidelines. METHODS: German evidence-based guidelines (data from January 2010; update will be done in July 2010) were assessed by 2 independent raters with DELBI with regard to quality indicators. If quality indicators referring to key recommendations were identified, the methodology of development was analyzed with respect to participation, modality and criteria of assessment, number, reference values, and piloting of quality indicators. RESULTS: Out of 76 guidelines, 60 (79%) did not contain any QI. 11 guidelines (14%) contained QI which did not refer directly to key recommendations. Only 5 guidelines (7%) comprised QI referring to key recommendations. Different methods of QI development were used. Three National Disease Management Guidelines (NDMG) applied a structured approach with criteria of the German quality indicator assessment tool QUALIFY, which led to 7 to 18 quality indicators. One guideline used the RAND/UCLA methodology (n ϭ 54 QI) and another guideline assessed quality indicators by the socalled "RUMBA" criteria (n ϭ 88 QI). All 5 guidelines used written assessment by the whole guideline group. Only in 2 guidelines were reference values indicated. No piloting of QI was described.
DISCUSSION (CONCLUSION):
Up to now the majority of German evidence-based guidelines do not contain QI referring to key recommendations. The few guideline groups deriving QI from key recommendations of guidelines use different methods. Advantages and disadvantages and further needs for development will be discussed. BACKGROUND (INTRODUCTION) : The Physician Consortium for Performance Improvement® (PCPI), convened by the American Medical Association, is a leading developer of evidence-based quality measures for health-care professionals. These measures are typically derived from clinical practice guidelines. Given the methodological inconsistencies found among guidelines, a PCPI advisory committee sought to standardize criteria by which guidelines could be objectively selected for use by PCPI measure development panels.
LEARNING OBJECTIVES (TRAINING GOALS):
1. Understand how the quality of guideline development methodology and documentation affects performance measures development. 2. Identify guideline elements currently required by PCPI for use in measure development and additional "preferred" or "high-priority" elements that will become PCPI requirements in the coming years.
METHODS:
Based on the published conclusions of earlier initiatives assessing guideline quality, the committee drafted preliminary PCPI requirements for guideline development methodology and content; less-critical guideline elements were rated "preferred." Selected guidelines used previously as the evidence base for PCPI measures were evaluated against the draft criteria. The committee then revised and finalized the criteria through an informal consensus development process; the criteria were also vetted among PCPI members before implementation. RESULTS: Less than one half of the previously-used guidelines passed the evaluation against the draft set of PCPI requirements. The committee agreed upon a more flexible set of criteria for initial implementation, with only three methodology and content elements rated "required." Other elements were downgraded to "preferred" or "high-priority" status but were scheduled for gradual reclassification as PCPI requirements in coming years. Options for deriving measures from alternative evidence review documents (conditionally) or from published results of successful quality improvement initiatives were also added to the final criteria statement approved by PCPI members.
DISCUSSION (CONCLUSION):
The flexible set of guideline criteria approved for initial implementation will facilitate the objective selection of guidelines for use by PCPI measure development panels. Additionally, with the process proposed for expanding PCPI requirements over time, the PCPI seeks to drive progressive improvements in the rigor of guideline development.
TARGET AUDIENCE(S):
1. Evidence synthesizer, developer of systematic reviews or meta-analyses 2. Guideline developer 3. Guideline implementer
